NICE Methods and Process Review Outcome: Key Messages

The ABPI is concerned that overall, the outcome of the review has not met the level of ambition that was anticipated, and clearly set out in the Government’s Life Sciences Vision. This, coupled with the implementation of the new Manual within a cost neutral envelope will restrict patients’ access to some types of new medicines and hold back the UK’s ambition to be a global life sciences hub.